07.28.21
In this special episode of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Ike Ahmed, MD; George Durr, MD; and Ticiana De Francesco, MD, share lessons learned on their use of the MicroShunt since its release. Together, they offer pre-operative, intra- operative, and post-operative suggestions, tips for patient selection, proper positioning, and more based on the retrospective clinical studies conducted, in part, by Dr. Durr and Dr. Ahmed.1,2 1. Durr GM, Schlenker MB, Samet S, Ahmed IIK. One-year outcomes of stand-alone ab externo SIBS MicroShunt implantation in refractory glaucoma. Br J Ophthalmol. 2020. Available at: bjophthalmol-2020-317299. Epub ahead of print. 2. Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS MicroShunt with mitomycin c. Am J Ophthalmol. 2020;215:141-153.
View full description +
Subscribe
08.15.25
Sustained Drug Delivery in Interventional GlaucomaI. Paul Singh, MD; Constance Okeke, MD, MSCE; and Zarmeena Vendal, MD
06.26.25
Survey Says: Choosing Treatment for a High-Risk PatientI. Paul Singh, MD; Erin Sieck, MD; and Arkadiy Yadgarov, MD
05.23.25
Career Change: Making the Vision Come to Life • Private Practice Versus AcademiaZahra Ali, MD; and Devang L. Bhoiwala, MD
03.19.25
Survey Says: Proceeding After Unsuccessful TreatmentI. Paul Singh, MD; Manjool Shah, MD; and Ticiana De Francesco, MD,
02.24.25
Impact of Selective Laser Trabeculoplasty on Diurnal IOP FluctuationCatherine Johnson, MD, MPH
Show More